/PRNewswire/ Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in antisense therapeutics, announced today that the U.S. Food and Drug Administration.
/PRNewswire/ Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced two appointments that strengthen its leadership team and further position it to.
CARLSBAD, Calif., Jan. 19, 2022 /PRNewswire/ Ionis Pharmaceuticals, Inc. today announced two appointments that strengthen its leadership team and further position it to become a. | January 19, 2022
Ionis Pharmaceuticals, inc (IONS) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.